CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
Qihang Wu, Cheng Fang, Xue Wang, Shuaishuai Huang, Guobin Weng · 2023
Read CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma by Qihang Wu, Cheng Fang, Xue Wang, Shuaishuai Huang, Guobin Weng (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10713979.txt.
Description
Wu leads a team studying a DNA-damage gene, CHEK2, as a prognostic marker in clear cell kidney cancer in a 2023 paper. The gene helps cells respond to genetic damage and is tied to several cancers. Its role in this kidney cancer was murky.
Tumor data from a major cancer atlas were mined for expression and outcome patterns. CHEK2 levels predicted survival on their own, beyond other factors. Enrichment analysis tied the gene to immune-related processes. Immune cell infiltration in tumors tracked with its expression. High levels also linked to resistance against some targeted drugs. The authors propose CHEK2 as a biomarker for prognosis and immune status. More work is needed before clinical use.
Catalog record
| CREATOR | Qihang Wu, Cheng Fang, Xue Wang, Shuaishuai Huang, Guobin Weng |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |